Acetylcholinesterase (AChE), the enzyme involved in the hydrolysis of the neurotransmitter acetylcholine, has been implicated in non-cholinergic actions which may play a role in neurodegenerative diseases such as Alzheimer's disease. To study the potential cytotoxicity of brain AChE, the effects of affinity purified AChE were analyzed on neuronal (Neuro 2a) and glial-like (B12) cells. LDH release and MTT reduction assays showed that AChE was toxic; the toxicity was dependent on the enzyme concentration, time of incubation and cellular density. The toxic effect of AChE was not related to its catalytic activity, since the anti-cholinesterase drug BW284C51 and heat inactivation were unable to block the effects of the enzyme. When cells were incubated at 4؇C, toxicity was completely blocked, in contrast to cells incubated at 37؇C. The presence of serum in the culture medium inhibited the toxic effects of AChE. Cytoplasmic shrinkage, condensation and fragmentation of nucleus as well as DNA strand breaks detected with the TUNEL technique indicated that apoptotic cell death is involved in the effect of AChE. Considering that we have previously shown that AChE promotes the assembly of ␤-amyloid peptide into neurotoxic amyloid fibrils, it is conceivable that the neurotoxicity of AChE shown here may play a role in the neuronal degeneration observed in Alzheimer's disease.
Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disease that involves loss of memory and higher cognitive functions. 1 Neurodegeneration involves specific systems such as the nucleus basalis of Meynert and the hippocampus. [2] [3] [4] [5] Neuropathologically, the disease is characterized by the presence of amyloid deposits in the brain, which are associated with senile plaques and neurofibrillary tangles. 3, 5 AD is a complex hereditary and sporadic disorder, linked to mutations in many genes, which give rise to similar clinical and pathological phenotypes. However, because known mutations on three identified loci on chromosomes 14, 1, and 21 (presenilin I, presenilin II and amyloid precursor protein) only account for hereditary cases (10-15% of all AD cases), there is a need to search for the mechanisms responsible for the progressive cognitive decline observed in sporadic cases, which correspond to the great majority of AD patients. [5] [6] [7] Although there is increasing interest in studying the molecular components of the lesions, the mechanisms by which neu-ronal degeneration arises in AD are still unclear. 8 The demonstration that the amyloid-␤-peptide (A␤), a small polypeptide of 40-42 amino acids, the principal constituent of senile plaques and vascular deposits, 3, 9 is neurotoxic in cell cultures gave rise to the hypothesis that A␤ may be the primary cause of neuronal degeneration in AD. 6, 8, 10 However, the selective nature of the neuronal populations damaged in AD suggests that other factors may also be involved. [11] [12] [13] [14] Several studies on brains displaying AD lesions have shown changes in the expression and distribution of acetylcholinesterase (AChE), the enzyme responsible for the hydrolysis of the neurotransmitter acetylcholine. [15] [16] [17] Firstly, AChE activity is lost in specific regions of the AD brain, such as the cortex, hippocampus, amygdala and nucleus basalis of Meynert. 2, 18, 19 Secondly, it was shown that transgenic mice overexpressing human AChE in brain neurons underwent progressive cognitive deterioration. 20 Thirdly, the relative proportions of the different forms of AChE change, with a decrease in the tetrameric globular G 4 AChE form [21] [22] [23] and a parallel increase in the monomeric G 1 24 and the asymmetric AChE forms, 23 although the latter normally corresponds to a small fraction of the total enzyme present in human brain. Finally, AChE has also been found to co-localize with A␤ deposits, such as those present in pre-amyloid diffuse deposits, mature senile plaques and cerebral blood vessels. 18, [25] [26] [27] All these facts suggest that AChE may play a role in the pathogenesis of AD. 11, 28 A␤ deposition is an important step in the neurodegenerative processes associated with AD. 3, 6, 8 However, there is as yet no explanation for the selective death of specific populations of neurons in AD brains. It is possible that components of senile plaques other than A␤ are involved in this selective neuronal cell death and AChE is one such candidate. In fact, among the neurons that degenerate in AD, there are populations that do not contain choline acetyltransferase yet still express AChE, 29, 30 suggesting that a major characteristic of degenerative neurons could be the expression of AChE. 11, 30 Furthermore, most of the cortical AChE activity present in AD brain has been found associated with senile plaques, where it co-localizes with A␤ deposits probably promoting the aggregation of A␤ into amyloid fibrils, thus increasing its toxicity. 13, 14 In order to determine whether AChE plays an active role in cell damage, the effect of exogenously applied AChE was examined on a neuronal and a glial-like cell line. A preliminary account of this work has been presented elsewhere.
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Materials and methods
Cell lines and culture
Neuro 2a is a neuronal cell line 32 derived from mouse neuroblastoma cells. 33 B12 is a glial-like cell line, derived from a collection of cell lines obtained from induced brain tumors in rats. 34 Neuro 2a and B12 cell lines were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum (FBS) and containing 100 g ml −1 streptomycin, 100 U ml −1 penicillin and 25 g ml −1 fungizone and maintained at 37°C, with an atmosphere of 5% CO 2 and Figure 1 Toxicity of purified AChE on B12 cells. B12 cells were incubated with increasing concentrations of the G 4 bovine form of AChE for 4 h. Toxicity was evaluated using the MTT reduction assay and LDH release into the medium. The graph corresponds to one representative experiment performed in triplicate. A total of eight experiments were carried out and the relative error was consistently less than 10%. AChE induced a concentration-dependent toxic effect as can be appreciated by the cytotoxicity parameters, with a gradual decrease in MTT reduction and an increase in LDH release. The control vehicle gave no decrease in MTT reduction or rise in LDH release. On the right, an SDS-PAGE 12% shows the purified G 4 enzyme (3 g) from bovine caudate nucleus. AChE concentrations were calculated taking into account the total number of catalytic subunits present in the tetrameric enzyme. saturated humidity. Neuro 2a and B12 cells were differentiated by incubation with 5 mM and 1 mM dibutyryl-cAMP respectively for 48 h prior to the experiment.
Purification of bovine AChE
The enzyme was purified from bovine caudate nucleus using an N-methylacridinium-Sepharose affinity column as described previously. 35 This procedure allowed the purification of the G 4 form of AChE, with a specific activity of 6000 U mg −1 of protein and almost 100% purity according to SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
AChE assay
The enzymatic activity of AChE was measured using the Ellman assay, 36 as described previously.
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Cytotoxic assays Neuro 2a and B12 cells were dissociated by trypsinization and seeded at a density of 3-4 × 10 3 cells per well on 96-well microtiter plates in 100 l of growth medium and maintained at 37°C with an atmosphere of 5% CO 2 . After 24 h culture media were changed for fresh media without Phenol red and fetal bovine serum (FBS). AChE was added with the final concentrations indicated in the text or figure legends. To assess cytotoxicity, two assays were utilized: the modified 3-[4,5-dimethylthiazol-2-yl]-2,5-dipheniltetrazolium bromide (MTT) assay, which measures metabolic activity and the lactic dehydrogenase (LDH) release assay, which indicates cell viability. 38 The MTT assay described by Mossman 39 was carried out by adding 11 l of a 5 mg ml −1 MTT solution to each well (110 l) and incubated for 2-4 h, after which the reaction was stopped with 100 l of a solution containing 50% dimethyl-formam- (b) B12 cells were seeded at different densities and the next day were exposed to 60 nM AChE for 8 h. A greater decrease in MTT reduction and increase in LDH release can be seen at lower cell densities. In both cases, the figure corresponds to one representative experiment performed in triplicate of a series of 3-5 experiments carried out in each case and the relative error was consistently less than 10%.
ide and 20% SDS (pH 4.8) . Absorption values at 540-650 nm were determined the following day, using an automatic microtiter plate reader (Uniskan, Helsinki, Finland) and MTT reduction results were expressed as a percentage of control (untreated) cells. LDH release was measured according to the manufacturer's instructions (Promega, WI, USA) and the results were expressed as a percentage of the total cellular LDH content of untreated cells.
Morphological changes: phase contrast and fluorescence microscopy
Neuro 2a and B12 cells in culture medium supplemented as described earlier were plated at a density of 3 × 10 4 cells per ml on glass coverslips. Cultures were left at 37°C with 5% CO 2 for 7 h. The culture medium was then changed for fresh medium supplemented with 1% FBS and antibiotics containing AChE at the desired concentrations for 13-16 h. Contrast phase micrographs of living cells were obtained using a Nikon phase inverted microscope. For phalloidin labeling experiments cells were fixed in 4% paraformaldehyde in PBS, permeabilized with 1% Tween 20 in PBS and then labeled with 50 M fluorescein isothiocyanate (FITC) conjugated phalloidin for 2 h at room temperature. After being washed with PBS, cells were mounted in 90% glycerol and labeling was observed under an Axioplan Zeiss fluorescent microscope.
In situ detection of DNA cleavage
Neuro 2a and B12 cells were plated at a density of 1.5 × 10 4 per well on 24-well plates in 0.5 ml of growth medium 24 h before the experiment. After incubation with different concentrations of AChE for 2 h, cells were fixed with 4% paraformaldehyde in PBS solution, pH 7.4 for 30 min at room temperature. Cells were then rinsed with PBS and incubated with 0.3% H 2 O 2 in methanol for 30 min at room temperature to block endogenous peroxidase. After rinsing with PBS, cells were incubated in permeabilization solution 0.1% Triton X-100 in 0.1% sodium citrate for 2 min on ice (4°C). Then cell cultures were processed with the In Situ Cell Death Detection kit POD (Boehringer Mannheim, Mannheim, Germany) based on terminal deoxynucleotidil transferase (TdT) mediated fluorescein-dUTP nick end labeling (TUNEL) 40, 41 following the manufacturer's instructions. The specificity of the method was determined by processing of duplicate samples in the absence of deoxynucleotide transferase.
Results
Toxicity of AChE: effect of enzyme concentration, time of incubation and cell density
To evaluate whether brain AChE plays a role in cell damage, the effect of exogenously-applied enzyme on neuronal and glial-like cell lines was examined. Cells were cultured in the presence of the bovine affinitypurified brain AChE. Toxicity was evaluated using the MTT reduction assay, an indicator of cell redox activity which serves as a marker for cellular metabolic state, and the LDH release assay which measures the release of this cytoplasmic soluble enzyme into the media after cell lysis. Figure 1 shows the concentration-dependent toxic response of B12 cells incubated with increasing concentrations of brain AChE. The increasing concentrations caused cell death, as reflected by the increasing LDH released. As a control, bovine serum albumin does not show cell death even at high protein concentrations (500 M) up to 5000 times the amount used for AChE (data not shown). The toxic effect of AChE was also time-dependent. Greater toxicity was observed when B12 cells treated with 60 nM AChE were incubated for longer periods of time (Figure 2a) . AChE toxicity was also dependent on the cellular density of the cultures. Exposure to AChE had a greater deleterious effect on cells cultured at low cell densities (Figure 2b ). The toxic effects of AChE observed on B12 cells were also seen on Neuro 2a cells, a neuronal cell line as well as on differentiated Neuro 2a and B12 cells (Table 1) . 
Morphological changes after addition of AChE to cultured cells
The morphology of cells exposed to AChE was clearly affected in a concentration-dependent manner, untreated B12 cells plated on plastic possessed good adhesive properties and normally showed several well developed extensions (Figure 3a ). However at low enzyme concentration, cells appeared swollen and gradually lost their extensions (Figure 3b ,c). They became rounded (Figure 3c ) and some developed blebs on the plasma membrane or underwent cell lysis (Figure 3d , see arrows). More detailed studies using FITC conjugated phalloidin, showed changes in actin filament arrangement after exposure to AChE. Normal B12 cells showed actin filaments arranged in conspicuous bundles and forming clusters at focal contacts ( Figure 3e , see arrows), whereas after treatment with AChE, phalloidin labeling became lighter and clusters were smaller than in control cells (Figure 3f) . One of the first events following AChE treatment was the disruption of focal adhesion contacts. AChE was also toxic to differentiated Neuro 2a (Figure 4a ) and B12 cells. When these cells were exposed to AChE, they showed loss of neurite extensions and became rounded, often showing blebs on the surface or cell lysis (Figure 4b ). Undifferentiated Neuro 2a cells showed short microspikes projecting from the edge of their lamellipodia which presented a brush-like distribution under normal conditions (Figure 4c ). Exposure to AChE changed the labeling pattern, cells became rounded, displayed fewer processes and lighter staining (Figure 4d ). Even cells with elongated processes showed only few or no actin bundles.
AChE induced DNA fragmentation
In order to approach the potential mechanism involved in the cell death triggered by AChE, both Neuro 2a and B12 glial-like cells were treated with AChE and then fixed and processed with the TUNEL assay to detect DNA fragmentation. This technique allows the specific labeling of 3′-OH ends of DNA generated in apoptotic cells. 40 The incubation of AChE with Neuro 2a and B12 cells induced the appearance of round cells with intense nuclear staining, cytoplasmic shrinkage, nuclear condensation and fragmentation (Figure 5b,d apoptosis. 42 No positive staining for apoptosis was observed in control cultures of Neuro 2a (Figure 5a ) and B12 (Figure 5b ) cells which conserved the globular shape of nuclei and the extended morphology of each cell line after the histochemical procedure.
The toxic effect of AChE is not related to its catalytic activity
In order to elucidate whether or not the toxic effect of AChE depends on its catalytic activity, various treatments inhibiting its enzymatic activity were tested. The enzyme was inhibited with BW284C51, a potent reversible inhibitor of the active site. 43 Pre-inhibited AChE was applied to the culture media in the presence of the inhibitor and the catalytic activity of AChE was controlled both before and during the experiment. Controls with the inhibitors alone were also done. Under such conditions, AChE was still toxic to B12 cells ( Figure 6 ). Decamethonium, an inhibitor of both the active and peripheral sites of AChE, 44 was also unable to block the toxicity of AChE (data not shown). The enzymatic activity of AChE was also eliminated by boiling the enzyme prior to its addition to the cell cultures. The heated enzyme was equally toxic to B12 cell cultures (Figure 6) , showing the same concentrationand time-dependent effect as the native enzyme.
AChE toxicity is inhibited by FBS and by the incubation of cells at low temperatures
Fetal bovine serum (FBS) was found to decrease AChE toxicity. When cells were incubated with AChE in complete growth media, higher concentrations of AChE were required to show its toxic effect and this effect was almost completely blocked by 5 or 10% FBS (Figure 7) . Preliminary chromatographic fractionation studies of FBS indicated that high molecular weight molecules are involved in the ability of FBS to protect against cell death. AChE toxicity was also dependent on the temperature at which cell cultures were incubated. After 1 h incubation at 37°C with increasing AChE concentrations, B12 cells showed a clear decrease in MTT reduction and an increase in LDH release. In contrast, when these cells were incubated at Figure 6 Toxicity of AChE is independent of its catalytic activity. The catalytic activity of AChE was inhibited or inactivated using different treatments. Firstly AChE was either pre-inhibited using BW284C51 or inactivated by heating before being added to the cell media and incubated for 4 h. Cytotoxicity parameters were then evaluated. B12 cells alone (control), incubated with 46 nM AChE previously inhibited with BW284C51 (AChE + BW), with BW184C51 alone as a control (BW) or with AChE inactivated by heating (denatured AChE). The toxicity of AChE was not prevented either by the inhibition or inactivation of the catalytic site of the enzyme. The catalytic activity of AChE was controlled using the Ellman assay, 36 at the beginning and at the end of the experiment.
4°C, the same concentrations of AChE did not induce changes in MTT reduction or LDH release (Figure 8 ).
Discussion
AChE accumulates in senile plaques, which are strongly associated with the neuronal degeneration that occurs in AD. In this context, AChE could have a toxic effect on brain cells that could be associated with Figure 7 Toxicity of AChE is prevented by FBS. B12 cells were incubated with media containing the indicated concentrations of FBS and 76 nM AChE for 12 h, after which the cytotoxicity parameters were evaluated. As can be seen, MTT reduction was almost totally eliminated and LDH release greatly inhibited, by concentrations of FBS over 5%.
Figure 8
Toxicity of AChE is sensitive to temperature. B12 cells were incubated with AChE at the indicated concentrations for 1 h at 37°C or at 4°C and then LDH released was measured and MTT reduction was determined for a period of 2 h at 37°C. The figure corresponds to one representative experiment done in triplicate from a series of four experiments. neuronal degeneration. 14 We analyzed the effects of exogenously applied affinity purified brain AChE on neuronal and glial cells in culture. Our results show that low concentrations of AChE (in the nM range) induced morphological and metabolic changes in Neuro 2a and B12 cells. Both cell types degenerated and eventually underwent cell death when exposed to higher levels of AChE. These responses were not only dependent on enzyme concentration, but also on the time of exposure and cell density.
The toxic effects of AChE were independent of its catalytic active site. Neither an inhibitor blocking its active site nor heat inactivation of the enzyme modified its cytotoxic effect. Effects independent of the catalytic activity of AChE have described as non-cholinergic actions of the enzyme, which include cellular effects such as the induction of neurite outgrowth, 45 respiratory bursts in macrophages and behavioral changes in rats 11, [46] [47] [48] Oligonucleosomal DNA degradation is one of the hallmarks of apoptotic 42 cell death. Our results using the TUNEL technique which detects DNA fragmentation in situ, strongly suggest that for both neuronal and glial-like cells, apoptotic cell death is at least one of the mechanisms by which AChE exerts its toxic effects. There are reports that apoptotic cell death takes place in AD, as demonstrated by the same TUNEL technique. 49, 50 The attenuation of the toxic effect of AChE when the cells were incubated at 4°C suggests that this toxicity is mediated by an energy-dependent process. At the present time, we cannot distinguish whether an endocytotic event, the activation of intracellular signaling or the nuclear transport are being inhibited. AChE could be internalized by cells in a temperature-dependent manner, as occurs with exogenously-applied AChE in the dopaminergic neurons of the substantia nigra. 46 On the other hand, it has been suggested that the respiratory burst induced by AChE in peritoneal macrophages is likely to be mediated by the macrophage mannose-fucose receptor, 47, 48 Future studies are planned in order to examine the possibility that AChE toxicity may be mediated via endocytosis.
The results of this study may be relevant in the context of the pathogenesis of AD. Despite the fact that our glial-like cells seem to be more sensitive to AChE injury than what is observed for glial cells in AD, 51 it must be taken into account that in cell cultures A␤ aggregates have been shown to be toxic for microglial cells. 52 The selective nature of the neuronal populations damaged in AD suggests that factors other than amyloid deposition are likely to be involved in the neurodegeneration. There is increasing information leading to the hypothesis that AChE may play a role in the neuronal cell death seen in AD. 13, 14 First, an important characteristic of the neurons that degenerate in AD seems to be the expression of AChE independent of whether they are cholinergic or not. 29 Second, most of the cortical AChE activity present in AD brain is found associated with senile plaques, 18 ,27 which in turn are related to neuronal degeneration. 8 Third, it has been reported that AChE is able to promote the aggregation of the A␤ peptide, 12 a condition that increases the A␤ toxicity. 8 All these facts suggest that AChE may indeed be involved in the pathogenesis of AD. The fact that AChE is toxic to cells in vitro, supports the conclusion that AChE may indeed contribute to neurotoxicity in vivo.
